← The Wire
EMBCNasdaq
Embecta Corp.
Surgical & Medical Instruments & Apparatus · DE · CIK 1872789
Embecta Corp. provides diabetes management solutions, including pen needles, syringes, and safety injection devices
⚡ Elevated coverage
$184M
Market cap
$3.31
Last close
-5.2%
1D
+9.2%
5D
1.8M
Volume
Price · last 39 sessions-64.2%
May 4L $2.90 · H $9.25Jun 29
75
Total filings
May 15, 2026
Last filing
09/30
Fiscal year end
8-KAcquisition / Disposition · Reg FD DisclosureMay 15, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 20268-KMaterial Agreement · Reg FD DisclosureMar 20, 20268-KShareholder VoteFeb 13, 202610-Q10-QFeb 5, 20268-KResults of OperationsFeb 5, 2026DEFA14ASCHEDULE 14AJan 23, 2026DEFA14ADEFA14ADec 18, 2025DEF 14ADEF 14ADec 18, 202510-K10-KNov 25, 20258-KResults of OperationsNov 25, 20258-KExecutive ChangeNov 17, 202510-Q10-QAug 8, 20258-KResults of OperationsAug 8, 20258-KReg FD DisclosureMay 22, 202510-Q10-QMay 9, 20258-KResults of OperationsMay 9, 20258-KShareholder VoteFeb 14, 202510-Q10-QFeb 6, 20258-KResults of OperationsFeb 6, 2025DEFA14ADEFA14ADec 19, 2024DEF 14ADEF 14ADec 19, 202410-K10-KDec 11, 20248-KExecutive ChangeDec 2, 20248-KResults of OperationsNov 26, 2024SC 13GSC 13GOct 25, 20248-KExecutive ChangeAug 12, 202410-Q10-QAug 9, 20248-KResults of OperationsAug 9, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 202410-K/A10-K/AApr 5, 20248-KMaterial AgreementMar 28, 2024SC 13GSC 13GFeb 12, 20248-KShareholder VoteFeb 9, 202410-Q10-QFeb 9, 20248-KResults of OperationsFeb 9, 2024SC 13GSC 13GJan 30, 2024DEFA14ADEFA14ADec 19, 2023DEF 14ADEF 14ADec 19, 202310-K10-KNov 29, 20238-KResults of Operations · Reg FD DisclosureNov 21, 2023SC 13GSC 13GSep 13, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KBylaw AmendmentAug 3, 20238-KExecutive ChangeJul 5, 202310-Q10-QMay 12, 20238-KResults of OperationsMay 12, 202310-Q10-QFeb 14, 2023SC 13GSC 13GFeb 14, 20238-KResults of OperationsFeb 14, 20238-KShareholder VoteFeb 13, 2023SC 13GSC 13GFeb 9, 2023SC 13GSC 13GJan 9, 2023DEFA14AFORM DEFA 14ADec 30, 2022DEF 14ADEF 14ADec 30, 202210-K10-KDec 22, 20228-KResults of OperationsDec 20, 2022SC 13GSC 13GNov 10, 20228-KCompany UpdateSep 30, 202210-Q10-QAug 15, 20228-KResults of OperationsAug 15, 202210-Q10-QMay 13, 20228-KResults of Operations · Reg FD DisclosureMay 13, 2022SC 13GSCHEDULE 13GMay 10, 2022SC 13GSC 13GMay 9, 20228-KExecutive Change · Material AgreementApr 6, 20228-KExecutive Change · Bylaw AmendmentMar 24, 20228-KReg FD DisclosureMar 23, 202210-Q10-QMar 16, 20228-KReg FD DisclosureMar 7, 20228-KCompany UpdateMar 4, 20228-KMaterial Agreement · New Debt / ObligationFeb 11, 2022
In the News
⚡ Elevated coverageCoverage (30d): 4 reputable articles · skews ▼ negative.
MorningstarEMBC UPCOMING DEADLINE: Levi & Korsinsky Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm5d agoBloomberg Law NewsEmbecta Is Sued Over Insulin Pen Part’s Revenue, 58% Stock Drop11d agoMorningstarEMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit12d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance